S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities

Verona Pharma (VRNA) Earnings Date, Estimates & Call Transcripts

$16.10
-0.30 (-1.83%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 29)
-$0.16 Beat By $0.07
Consensus EPS
(Feb. 29)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

VRNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VRNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Verona Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.24)($0.03)($0.14)
Q2 20242($0.32)($0.04)($0.18)
Q3 20242($0.32)($0.28)($0.30)
Q4 20242($0.40)($0.31)($0.36)
FY 20248($1.28)($0.66)($0.97)
Q1 20251($0.16)($0.16)($0.16)
Q2 20251($0.08)($0.08)($0.08)
Q3 20251($0.08)($0.08)($0.08)
Q4 20251($0.01)($0.01)($0.01)
FY 20254($0.33)($0.33)($0.33)

VRNA Earnings Date and Information

Verona Pharma last released its quarterly earnings results on February 29th, 2024. The reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.07. Verona Pharma has generated ($0.69) earnings per share over the last year (($0.69) diluted earnings per share). Earnings for Verona Pharma are expected to grow in the coming year, from ($1.32) to ($0.85) per share. Verona Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Verona Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/29/2024Q4 2023($0.23)($0.16)+$0.07($0.16)--
11/2/2023Q3 2023($0.27)($0.18)+$0.09($0.18)--
8/3/2023Q2 2023($0.27)($0.11)+$0.16($0.11)--
5/9/2023Q1 2023($0.22)($0.24)($0.02)($0.24)--
3/7/2023Q4 2022($0.22)($0.16)+$0.06($0.16)-$0.46 million    
11/9/2022Q3 2022($0.30)($0.24)+$0.06($0.24)--    
8/9/2022Q2 2022($0.35)($0.32)+$0.03($0.32)--
5/3/2022Q1 2022($0.47)($0.40)+$0.07($0.40)--
3/3/2022Q4 2021($0.50)($0.40)+$0.10($0.40)--
11/9/2021Q3 2021($0.19)$0.17+$0.36$0.17$25.00 million$40.00 million
8/5/2021Q2 2021($0.39)($0.56)($0.17)($0.56)--
4/29/2021Q1 2021($0.45)($0.55)($0.10)($0.55)--  

Verona Pharma Earnings - Frequently Asked Questions

When is Verona Pharma's earnings date?

Verona Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on VRNA's earnings history.

Did Verona Pharma beat their earnings estimates last quarter?

In the previous quarter, Verona Pharma (NASDAQ:VRNA) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.07. Learn more on analysts' earnings estimate vs. VRNA's actual earnings.

How much revenue does Verona Pharma generate each year?

Verona Pharma (NASDAQ:VRNA) has a recorded annual revenue of $460,000.00.

How much profit does Verona Pharma generate each year?

Verona Pharma (NASDAQ:VRNA) has a recorded net income of -$54.37 million. VRNA has generated -$0.69 earnings per share over the last four quarters.

What is Verona Pharma's EPS forecast for next year?

Verona Pharma's earnings are expected to grow from ($1.32) per share to ($0.85) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VRNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners